These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 10888241)

  • 41. Variation in lipoprotein(a) concentrations among individuals with the same apolipoprotein (a) isoform is determined by the rate of lipoprotein(a) production.
    Rader DJ; Cain W; Zech LA; Usher D; Brewer HB
    J Clin Invest; 1993 Feb; 91(2):443-7. PubMed ID: 8432853
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Lipoprotein (a) level, apolipoprotein (a) size, and risk of unexplained ischemic stroke in young and middle-aged adults.
    Beheshtian A; Shitole SG; Segal AZ; Leifer D; Tracy RP; Rader DJ; Devereux RB; Kizer JR
    Atherosclerosis; 2016 Oct; 253():47-53. PubMed ID: 27575936
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Method-dependent increase in lipoprotein(a) in insulin-dependent diabetes mellitus during pregnancy.
    Pekelharing HL; Aalders NL; Visser GH; van Doormaal JJ; Bouma BN; Kleinveld HA; van Rijn HJ
    Metabolism; 1995 Dec; 44(12):1606-11. PubMed ID: 8786731
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of Lp(a) rather than integrally-bound apo(a) with triglyceride-rich lipoproteins of human subjects.
    Marcoux C; Lussier-Cacan S; Davignon J; Cohn JS
    Biochim Biophys Acta; 1997 Jun; 1346(3):261-74. PubMed ID: 9219911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Molecular basis of apolipoprotein (a) isoform size heterogeneity as revealed by pulsed-field gel electrophoresis.
    Lackner C; Boerwinkle E; Leffert CC; Rahmig T; Hobbs HH
    J Clin Invest; 1991 Jun; 87(6):2153-61. PubMed ID: 1645755
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Sequence polymorphisms in the apolipoprotein (a) gene. Evidence for dissociation between apolipoprotein(a) size and plasma lipoprotein(a) levels.
    Cohen JC; Chiesa G; Hobbs HH
    J Clin Invest; 1993 Apr; 91(4):1630-6. PubMed ID: 8473506
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Apo(a)-isoform size, nutritional status and inflammatory markers in chronic renal failure.
    Stenvinkel P; Heimbürger O; Tuck CH; Berglund L
    Kidney Int; 1998 May; 53(5):1336-42. PubMed ID: 9573549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The apolipoprotein (a) gene: a transcribed hypervariable locus controlling plasma lipoprotein (a) concentration.
    Kraft HG; Köchl S; Menzel HJ; Sandholzer C; Utermann G
    Hum Genet; 1992 Nov; 90(3):220-30. PubMed ID: 1336760
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The association of serum lipoprotein(a) levels, apolipoprotein(a) size and (TTTTA)(n) polymorphism with coronary heart disease.
    Kalina A ; Császár A; Füst G; Nagy B; Szalai C; Karádi I; Duba J; Prohászka Z; Horváth L; Dieplinger H
    Clin Chim Acta; 2001 Jul; 309(1):45-51. PubMed ID: 11408005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of five mouse monoclonal antibodies to apolipoprotein[a] from human Lp[a]: evidence for weak plasminogen reactivity.
    Guo HC; Armstrong VW; Luc G; Billardon C; Goulinet S; Nustede R; Seidel D; Chapman MJ
    J Lipid Res; 1989 Jan; 30(1):23-37. PubMed ID: 2521888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [New data about lipoprotein(a): a curious molecule or a causal cardiovascular risk factor?].
    de Brouckère V; Liénart F; Ducobu J
    Rev Med Brux; 2010; 31(3):171-6. PubMed ID: 20687444
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relationship between apo(a) length polymorphism and lipoprotein(a) concentration in healthy Ivorian subjects with single or double apo(a) isoforms.
    Edjème-Aké A; Garnotel R; Vallée-Polneau S; Anglés-Cano E; Monnet D; Gillery P
    Clin Biochem; 2008 Sep; 41(13):1039-43. PubMed ID: 18582452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Differential expression of double-band apolipoprotein(a) phenotypes in healthy Spanish subjects detected by SDS-agarose immunoblotting.
    Martín S; Ladona MG; Pedro-Botet J; Covas MI; Rubiés-Prat J
    Clin Chim Acta; 1998 Oct; 277(2):191-205. PubMed ID: 9853702
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Atorvastatin lowers lipoprotein(a) but not apolipoprotein(a) fragment levels in hypercholesterolemic subjects at high cardiovascular risk.
    Gonbert S; Malinsky S; Sposito AC; Laouenan H; Doucet C; Chapman MJ; Thillet J
    Atherosclerosis; 2002 Oct; 164(2):305-11. PubMed ID: 12204802
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High lipoprotein(a) levels with predominance of high molecular weight apo(a) isoforms in patients with pulmonary embolism.
    Császár A; Karádi I; Juhász E; Romics L
    Eur J Clin Invest; 1995 May; 25(5):368-70. PubMed ID: 7628525
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Corticotropin-induced reduction of plasma lipoprotein(a) concentrations in healthy individuals and hemodialysis patients: relation to apolipoprotein(a) size polymorphism.
    Arnadottir M; Berg AL; Kronenberg F; Lingenhel A; Hugosson T; Hegbrant J; Nilsson-Ehle P
    Metabolism; 1999 Mar; 48(3):342-6. PubMed ID: 10094111
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Serum lipoprotein(a) concentration and Apo(a) isoform under the condition of renal dysfunction.
    Kuboyama M; Ageta M; Ishihara T; Fujiura Y; Kashio N; Ikushima I
    J Atheroscler Thromb; 2003; 10(5):283-9. PubMed ID: 14718745
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lipoprotein(a) as a risk factor for coronary artery disease.
    Marcovina SM; Koschinsky ML
    Am J Cardiol; 1998 Dec; 82(12A):57U-66U; discussion 86U. PubMed ID: 9915664
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A common nonsense mutation in the repetitive Kringle IV-2 domain of human apolipoprotein(a) results in a truncated protein and low plasma Lp(a).
    Parson W; Kraft HG; Niederstätter H; Lingenhel AW; Köchl S; Fresser F; Utermann G
    Hum Mutat; 2004 Dec; 24(6):474-80. PubMed ID: 15523644
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.